Citadel Advisors - WEREWOLF THERAPEUTICS INC ownership

WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 49 filers reported holding WEREWOLF THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of WEREWOLF THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$26,096
-70.7%
12,730
-36.8%
0.00%
Q1 2022$89,00020,1440.00%
Other shareholders
WEREWOLF THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DC Funds, LP 589,102$1,531,66535.68%
MPM ASSET MANAGEMENT LLC 4,284,172$11,138,8474.64%
MPM BioImpact LLC 2,388,011$6,208,8291.61%
RA Capital Management 6,144,881$15,976,6910.36%
SPHERA FUNDS MANAGEMENT LTD. 626,810$1,629,7060.27%
PFM Health Sciences, LP 2,217,220$5,764,7720.26%
Rubric Capital Management LP 1,935,357$5,031,9280.13%
Laurion Capital Management LP 522,900$1,359,5400.01%
Alyeska Investment Group, L.P. 397,808$1,034,3010.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 81,711$212,4490.01%
View complete list of WEREWOLF THERAPEUTICS INC shareholders